Healthcare Analysts provide an update to the Urticaria Landscape (relevant companies CLDX JSPR ALLK) on an Analyst/Industry conference call to be held on January 10.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDX:
- Jasper BEACON data ‘net positive,’ says BMO Capital
- Jasper data alleviates competitive concerns for Celldex, says Citi
- Celldex share decline an overreaction, says Cantor Fitzgerald
- Celldex initates Phase 2 study of barzolvolimab in AD
- Celldex announces first patient dosed in Phase 1a study of CDX-622